“JUBI-R” Remdesivir launched by Jubilant Life Sciences for the treatment of COVID-19 patients
THD NewsDesk, Mysore: In a recent turn of events, Jubilant Life Sciences has declared that its ancillary, Jubilant Generics launched ...
THD NewsDesk, Mysore: In a recent turn of events, Jubilant Life Sciences has declared that its ancillary, Jubilant Generics launched ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily